Company intelligence / Profile preview

Hemobrás

Brazil
Ownership
Private
Employees
~175
Development stage
Other
01

Overview

Hemobrás produces and supplies blood-derived medicines including albumin, immunoglobulin, and coagulation factors to Brazil's public health system.

Therapeutic areas
HematologyImmunologyDermatology
Modalities
Recombinant proteinBiologic
Industry
Biotech
02

Partnerships

Takeda Pharmaceutical

Beyond the preview

Go deeper on Hemobrás.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemobrás.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call